![]() ![]() The AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the impact of legal recreational marijuana use laws on patient and societal health.The AAFP calls for decreased regulatory barriers to facilitate clinical and public health cannabis research, including reclassifying cannabis from a Schedule I controlled substance.This process should also ensure appropriate funding allocated for this research. The AAFP advocates for further studies into the use of medical marijuana and related compounds.The AAFP recognizes there is support for the medical use of marijuana and cannabinoids, but advocates that usage be based on high-quality, evidence-based public health, policy, and patient-centered research, including the impact on vulnerable populations.The AAFP promotes a society which is free of substance misuse, including alcohol and drugs. ![]() The AAFP recognizes the need for substantial clinical, public health, and policy evidence and research regarding cannabis, marijuana, cannabinoids, and CBD to inform evidence-based practice and the impact on public health. This shift has not been accompanied by robust scientific research regarding the health effects of cannabis, both therapeutic or detrimental. The regulatory environment surrounding cannabis, medical and recreational marijuana, and cannabidiol (CBD) is rapidly changing, along with the retail environment. Substances derived from the cannabis plant include marijuana, hemp, and cannabinoids.įamily physicians have a vested interest in policies that advance and protect the health of their patients and the public. In this position paper, cannabis is an overarching term used to refer to the plant Cannabis sativa. It should be noted that cannabis and marijuana are not interchangeable terms. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP also recognizes that several states have passed laws approving limited recreational use and/or possession of marijuana. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth. However, the AAFP supports decriminalization of possession of marijuana for personal use. The American Academy of Family Physicians (AAFP) opposes the recreational use of marijuana. The lack of regulation poses a danger to public health and impedes meaningful, patient-centered research to exploring both therapeutic and negative impacts of marijuana and cannabinoids. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. 2ĭuring the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use. The World Health Organization (WHO) reports approximately 2.5% of the global population uses cannabis annually, making it the most commonly used drug worldwide. The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The American Academy of Family Physicians (AAFP) believes family physicians are essential in addressing all forms of inappropriate substance use. Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |